Condition

Major Neurocognitive Disorder clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Major Neurocognitive Disorder clinical trials that are recruiting, at sites in 3 countries (most in Switzerland (1), Italy (1), Canada (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Major Neurocognitive Disorder clinical trials

StudyPhaseWhereStatusRegistered
Validation of Italian cognitive assessment scales for elderly patients — Milan, Michigan Recruiting Nov 22, 2024
Exergaming for improving health in dementia patients — Wetzikon, Canton of Zurich Recruiting Oct 8, 2024
Improving medication management for seniors with major neurocognitive disorders — Montreal, Quebec and 1 other locations Recruiting May 17, 2021

All recruiting trials (3)

Related topics

Alzheimer DiseaseLewy Body DementiaMild Cognitive Impairment (MCI)Parkinson DiseaseSubjective Cognitive Decline (SCD)

Quick answers

How many Major Neurocognitive Disorder clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Switzerland (1 trial), Italy (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.